Sunday’s Midday Movers: Renesola (SOL), Himax Technologies (HIMX), Inovio Pharmaceuticals (INO), Novavax (NVAX), Navios Maritime Partners (NMM)

So far Sunday, November 29, NASDAQ is up 1.12% and the S&P is down -0.27%. Here are this morning’s most active stocks: Renesola (SOLResearch Report), Himax Technologies (HIMXResearch Report), Inovio Pharmaceuticals (INOResearch Report), Novavax (NVAXResearch Report) and Navios Maritime Partners (NMMResearch Report).

Renesola is up 26.77% in midday trading to $7.34. Shares opened today at $5.79. The company has a 52-week low of $0.85 and a 52-week high of $8.39. On the Street’s front, the average 12-month analyst price target for the stock is $4.00, marking a -30.92% potential downside from current levels. In a report issued on September 29, H.C. Wainwright analyst Amit Dayal maintained a Buy rating on SOL, with a price target of $4.00, which implies a downside of 31% from current levels.

Himax Technologies is up 20.51% in midday trading to $7.05. Shares opened today at $5.85. The company has a 52-week low of $1.73 and a 52-week high of $7.00. On the Street’s front, the average 12-month analyst price target for the stock is $4.25, marking a -27.35% potential downside from current levels. In a report issued on November 17, Northland Securities analyst Gus Richard maintained a Hold rating on HIMX, with a price target of $4.50, which reflects a potential downside of -23% from last closing price.

Inovio Pharmaceuticals is up 18.3% in midday trading to $12.41. Shares opened today at $10.49. The company has a 52-week low of $2.28 and a 52-week high of $33.79. On the Street’s front, the average 12-month analyst price target for the stock is $14.17, marking a 35.08% potential upside from current levels. In a report issued on November 24, H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on INO. Separately, on November 20, Maxim Group’s Jason McCarthy reiterated a Buy rating on the stock and has a price target of $20.00.

See today’s analyst top recommended stocks >>

Novavax is up 14.72% in midday trading to $124.01. Shares opened today at $108.10. The company has a 52-week low of $3.65 and a 52-week high of $189.40. On the Street’s front, the average 12-month analyst price target for the stock is $179.00, marking a 65.59% potential upside from current levels. In a report issued on November 17, H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on NVAX, with a price target of $207.00, which represents a potential upside of 91% from where the stock is currently trading. Separately, on November 10, Ladenburg Thalmann’s Michael Higgins reiterated a Sell rating on the stock and has a price target of $75.00.

See today’s analyst top recommended stocks >>

Navios Maritime Partners is up 12.5% in midday trading to $8.10. Shares opened today at $7.20. The company has a 52-week low of $4.08 and a 52-week high of $18.96. On the Street’s front, the average 12-month analyst price target for the stock is $7.00, marking a -2.78% potential downside from current levels. In a report issued on October 23, Jefferies Co. analyst Randy Giveans maintained a Hold rating on NMM, with a price target of $7.00, which represents a slight downside potential from current levels.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.